Effect of ursodeoxycholic acid on liver function and lipid, carbohydrate, and purine metabolism in the combination treatment of patients with metabolic dysfunction-associated steatotic liver disease: a prospective, randomized, open-label, parallel-group comparative study
Objective — to improve treatment efficacy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) by evaluating the effect of ursodeoxycholic acid (UDCA) as part of combination treatment on liver function parameters and lipid, carbohydrate, and purine metabolism. Materials and methods. This pr...